Page 62 - JCBP-2-1
P. 62

Journal of Clinical and
            Basic Psychosomatics                                                  Exteroceptive/interoceptive processing



            controls (HCs). We expected to observe stable differences   2.3. Study protocol
            (or similarities) in perceptual profiles when comparing   For PSY patients, the first evaluation was conducted within
            PSY-T1 with HC and, likewise, when comparing PSY-T2   48 h of admission to the Acute Psychiatric Inpatient Unit
            with HC.
                                                               (T0, acute phase), during which the Positive and Negative
                                                                                   [25]
            2. Methods                                         Syndrome Scale (PANSS)  was administered and scored
                                                               by a trained medical doctor. Perceptual profiles (MAIA
            2.1. Study design                                  and AASP) were not collected at this time point due to
            We performed a monocentric observational longitudinal   the potentially excessive distress their administration
            study that adhered to the  STrengthening the Reporting   could have caused to participants. The second evaluation
            of OBservational studies in Epidemiology (STROBE)   (T1, post-acute phase) took place at discharge. Patients
            guidelines . In compliance with the Declaration of   were  re-evaluated  using  PANSS,  and  the  MAIA  and
                    [24]
            Helsinki, our research received approval from the local   AASP questionnaires were administered  to assess
                                                                                                  [20]
            ethical  committee  of  the  IRCCS  Policlinico  San  Matteo   interoceptive and exteroceptive profiles,  respectively.
            (Pavia, Italy) under protocol number 20210003663. Each   Demographic  variables,  including  age,  gender,  DSM-5
            participant  was  informed  of  the  study’s  purposes  and   diagnosis, illness duration, mean antipsychotic dosage
            provided written informed consent in accordance with   (olanzapine equivalents) , mean antidepressant dose
                                                                                   [26]
            their legal civilian capabilities.                 (fluoxetine equivalents) , and mean benzodiazepine dose
                                                                                  [27]
                                                               (diazepam equivalents) , were collected at this time point.
                                                                                 [28]
            2.2. Participants                                  The final assessment (T2) was performed 6 – 12  weeks
            We recruited 23 PSY patients who were admitted to the   after discharge and involved the same tests administered at
            Acute Psychiatric Inpatient Unit of ASST Pavia at IRCCS   T1. The timing of assessment at T2 varied, as participants
            Policlinico San Matteo in Pavia, Italy, between May 1 ,   needed to be free from active symptoms that would
                                                         st
            2021 and May 1 , 2022. The sampling procedure used   require hospitalization. In the present study, remission was
                          st
            was convenience based; the study was proposed to all the   defined not solely as the absence of symptom s but rather
            patients hospitalized during the indicated period who met   as the  absence of  an  acute psychotic phase. HCs were
            the inclusion and exclusion criteria. Those who agreed to   administered only the AASP and MAIA questionnaires at
            participate were enrolled in the study. Inclusion criteria   a single time point.
            encompassed age between 18 and 65, a DSM-5 diagnosis
            of  psychotic  disorder  (including  schizophrenia,  other   2.4. Measurements of outcomes
            psychotic disorders, psychosis due to substance use, and   The MAIA is an instrument designed to evaluate
            psychosis  not  otherwise  specified),  or  unipolar/bipolar   subjective sensitivity  toward inner  body  sensations.  It
            mood disorder with psychotic symptoms, fluency in   consists of 32 items scored according to the frequency
            Italian, and the ability to sign a written informed consent.   of each behavior, with “0” indicating “never” and “5”
            Exclusion criteria included comorbid neurological   indicating “always.” These items are grouped into eight
            disorders that may be the primary cause of psychotic   subscales: “Noticing,” “Not distracting,” “Not worrying,”
            symptoms, intellectual disability, and any permanent   “Attention regulation,” “Emotional awareness,” “Self-
            condition potentially  impairing sensory processing   regulation,” “Body listening,” and “Trusting.” In addition to
            (i.e., blindness, deafness, major motor concerns, dysgeusia,   its application in psychosis [29,30] , the MAIA questionnaire
            and anosmia). Evaluations were carried out  by trained   has been used in various psychiatric conditions, such as
            medical doctors, and all diagnoses were confirmed by   autism, eating disorders, depression, and other disorders
            two psychiatrists according to DSM-5 criteria. We also   involving interoception, such as chronic pain syndrome,
            collected data from 210 HC selected from the general   fibromyalgia, and low back pain [20,22,31-36] .
            population. Inclusion criteria for HC were age between 18
            and 65, fluency in Italian, and the ability to sign a written   The AASP is an evaluation scale designed to measure
            informed consent. Exclusion criteria encompassed being   individual responses to sensory experiences encountered
            diagnosed with a psychiatric disorder and/or intellectual   in everyday life. Participants were asked to indicate the
            disability, use of psychoactive substances within 1 month   frequency with which they adopt specific behaviors, ranging
            before test submission, and any permanent condition   from rarely (5% or less of the time) to very frequently (95%
            potentially impairing sensory processing (i.e., blindness,   or more of the time). The AASP scale consists of 60 items
            deafness, major motor concerns, dysgeusia, and anosmia).   subdivided into four major categories that evaluate specific
            Furthermore, patients subject to a legal guardianship   responses to sensory stimuli. The “Sensory sensitivity” and
            measure were preventively excluded from the study.  “Low regulation” subscales evaluate the passive sensory


            Volume 2 Issue 1 (2024)                         3                        https://doi.org/10.36922/jcbp.1764
   57   58   59   60   61   62   63   64   65   66   67